Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The latest announcement is out from MedAdvisor Limited ( (AU:AHE) ).
Adheris Health Limited has notified the market that 8,889 AHEAT options, which were due to expire in March 2031, have lapsed because their specified conditions were not, or could no longer be, satisfied. The cessation of these conditional rights modestly reduces the company’s potential future diluted capital base and signals that the performance or vesting milestones tied to these options were not achieved, which may be relevant to investors tracking management incentives and capital structure changes.
The most recent analyst rating on (AU:AHE) stock is a Hold with a A$0.02 price target. To see the full list of analyst forecasts on MedAdvisor Limited stock, see the AU:AHE Stock Forecast page.
More about MedAdvisor Limited
Adheris Health Limited, listed on the ASX under the code AHE, operates in the healthcare sector. The company’s securities include options and other equity instruments that form part of its capital structure and are subject to performance or other conditional hurdles as part of its incentive or financing arrangements.
Average Trading Volume: 490,002
Technical Sentiment Signal: Sell
Current Market Cap: A$12.74M
See more insights into AHE stock on TipRanks’ Stock Analysis page.